Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Neurocognitive functioning and cannabis use in schizophrenia.
Aviv Segev
*
,
Shaul Lev-Ran
*
Corresponding author for this work
Psychiatry
Shalvata Mental Health Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neurocognitive functioning and cannabis use in schizophrenia.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cannabis
100%
Cannabis Use
100%
Clinical Aspects
14%
Cognitive Effects
14%
Cognitive Function
28%
Cognitive Functioning
14%
Cognitive Impairment
14%
Cognitive Measures
14%
Drug Use
14%
Endocannabinoid System
14%
Executive Function
14%
Illicit Drugs
14%
Inconsistency
14%
Memory Processing
14%
Memory-guided Attention
14%
Methodological Issues
14%
Neurocognitive Function
100%
Neurotransmission
14%
Patient Selection
14%
Processing Speed
14%
Psychomotor
14%
Schizophrenia
100%
Schizophrenic Patients
71%
Visuospatial
14%
Neuroscience
Cannabis
100%
Cognitive Control
10%
Cognitive Disorders
10%
Cognitive Effect
10%
Cognitive Function
20%
Dementia Praecox
100%
Endocannabinoid System
10%
Executive Functions
10%
Neurotransmission
10%
Psychology
Cognitive Control
10%
Cognitive effects
10%
Cognitive Function
20%
Cognitive Functioning
10%
Cognitive Impairment
10%
Executive Functions
10%
Neurotransmission
10%
Processing Speed
10%
Schizophrenia
100%